Skip to content

Investigation of the Postprandial Response of Two Different PDO Cheeses on Metabolic Biomarkers

Postprandial Inflammatory and Metabolic Responses Induced by the Authentic Ladotyri Mytilinis PDO Cheese and Italian Parmesan PDO Cheese

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05788887
Acronym
LadotyriCT
Enrollment
10
Registered
2023-03-29
Start date
2022-01-10
Completion date
2022-01-17
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Ladotyri Mytilinis PDO cheese, Postprandial response

Brief summary

The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.

Detailed description

A pilot cross-over, randomized and single-blinded, intervention-clinical trial was conducted, in ten healthy men and women subjects, aged eighteen to thirty years, after random allocation into the control and the intervention group, received a high-fat and carbohydrates meal, containing Ladotyri Mytilinis (the authentic nonrefrigerated recipe) or Italian Parmesan, PDO cheeses. After a washout week, participants consumed the same meals, conversely. Differences on postprandial responses of serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.

Interventions

OTHERAuthentic Ladotyri Mytilinis PDO cheese

Branding PDO cheese from Mytilini, purchasing by E.Thimelis Dairy S.A.

OTHERControl

Branding Parmesan PDO cheese from Italy, supplied by LIDL Hellas

Sponsors

E.Thimelis Dairy S.A.
CollaboratorUNKNOWN
University of the Aegean
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Only investigator knew the type of meal, consumed by each participant

Intervention model description

In the first trial period, participants in arm a consumed a meal containing 100g of white wheat bread and 80g of Italian Parmesan PDO cheese and arm b participants consumed a meal containing 100g of white wheat bread and 80g of Authentic Ladotyri Mytilinis PDO cheese. After a washout week participants consumed the meals, in reverse.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-65 years * Willingness to join and complete the nutritional intervention

Exclusion criteria

* Inability or unwillingness to provide informed consent * Three-month nutritional supplement * Age over 65 years or below 18 years * Chronic diseases history * Hemoglobin A1c - HbA1c \> 5.7 % * Abnormal Body Mass Index (BMI) (\> 25 kg / m2) * Abnormal hematological or biochemical profile (total cholesterol \> 240 mg/dL, triglycerides \> 250 mg/dL, glucose \> 100 mg/dL) * Alcohol overdose (\> 40 g alcohol / day) * Heavy smoking (\> 10 cigarettes / day) * Concurrent participation in another intervention study or unconsciousness in previous blood draws

Design outcomes

Primary

MeasureTime frameDescription
Changes from baseline of Total Antioxidant Capacity at 30 minutes, 1.5 hours and 3 hours3 hoursPlasma antioxidant activity

Secondary

MeasureTime frameDescription
Changes from baseline of glucose at 30 minutes, 1.5 hours and 3 hours3 hoursSerum glucose levels
Changes from baseline of total Cholesterol at 30 minutes, 1.5 hours and 3 hours3 hoursSerum total cholesterol levels
Changes from baseline of High Density Lipoprotein cholesterol (HDL-) at 30 minutes, 1.5 hours and 3 hours3 hoursSerum High Density Lipoprotein levels
Changes from baseline of Low Density Lipoprotein cholesterol (LDL-) at 30 minutes, 1.5 hours and 3 hours3 hoursSerum High Density Lipoprotein levels
Changes from baseline of triglycerides at 30 minutes, 1.5 hours and 3 hours3 hoursSerum triglycerides levels
Changes from baseline of Uric Acid at 30 minutes, 1.5 hours and 3 hours3 hoursSerum uric acid levels

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026